Amidst a share value slump and executive turmoil, Pfizer reported a robust quart...
The company has axed 80% of its staff and is considering a wind-down after the o...
As the Horizon acquisition reaps its benefits, Amgen is now turning eyes to its ...
Reeves' budget promised investment for innovation and R&D with a view to "harnes...
Experts predict that physicians may favour emerging biosimilar versions of Stela...
AbbVie has entered a definitive agreement to acquire all outstanding equity of A...
The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2024 is a st...
As the retail drug pharmacy space undergoes significant change, new formats and ...
UPFs have become a staple of many diets worldwide, but overconsumption is contri...
The SIRT6 activator’s sex-specific effects shed light on the different genetic p...
Organon has completed the acquisition of Dermavant Sciences, a subsidiary of Roi...
The registrational trial is expected to support the approval for Bavarian’s mpox...
At the Outsourcing in Clinical Trials Conference, US government personnel advise...
The EC has approved AstraZeneca's Fasenra as an add-on therapy for adults with r...
South Korea’s Ministry of Health and Welfare recently disclosed its proposal to ...
